Precision Medicine Approaches to Renal Osteodystrophy
Sponsor: |
National Institute of Health |
Enrolling: |
Male and Female Patients |
Study Length: |
6 Months |
Clinic Visits: |
4 |
IRB Number: |
AAAU1119 |
Contact: |
Mishaela Rubin: / mrr6@cumc.columbia.edu |
Precision Medicine Approaches to Renal Osteodystrophy is a study designed to discover new markers of how the kidney affects your bone health. This study will evaluate how your bone is reacting to your kidney problem both before and after you start your bone treatment for hyperparathyroidism or osteoporosis. We are looking for people who are interested in learning about their bone health. There will be a total of 4 visits over six months for this research study. You will have some questionnaires, research blood draws, bone imaging scans (high-resolution peripheral quantitative computed tomography HR-pQCT) and a Bone Biopsy. You will receive compensation up to $1000 for completing all visits. In the future, the results can contribute to developing strategies to improve bone health.
This study is closed
Investigator
Mishaela Rubin, MD
Have you been diagnosed with chronic kidney disease? |
Yes |
No |
Are you undergoing a clinically indicated treatment for bone disease such as renal hyperparathyroidism and osteoporosis? |
Yes |
No |
Are you planning on have a kidney transplant in the next 6 months? |
Yes |
No |
Did you have a kidney or any other organ transplant in less than 1 year? |
Yes |
No |
Do you have any allergies to tetracycline or demeclocycline antibiotics? |
Yes |
No |